Department of Clinical Sciences, Genetic and Molecular Epidemiology Unit, Lund University, Skåne University Hospital, SE-21741 Malmö Sweden; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden; Department of Nutrition, Harvard School of Public Health, Boston, MA, USA.
Diabetes Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA; Programs in Metabolism and Medical & Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Curr Opin Genet Dev. 2018 Jun;50:35-40. doi: 10.1016/j.gde.2018.02.001. Epub 2018 Feb 20.
Type 2 diabetes (T2D) is widespread, affecting the health of hundreds of millions worldwide. The disease results from the complex interplay of lifestyle factors acting on a backdrop of inherited DNA risk variants. Detecting and understanding biomarkers, whether genotypes or other downstream biological features that dictate a person's phenotypic response to different lifestyle exposures, may have tremendous utility in the prevention of T2D. Here, we explore (i) evidence of how human genetic adaptation to diverse local environments might interact with lifestyle factors in T2D, (ii) the key challenges facing the research area of gene×lifestyle interactions in T2D, and (iii) the solutions that might be pursued in future studies. Overall, many preliminary examples of such interactions exist, but none is sufficient to have a major impact on clinical decision making. Future studies, integrating genetics and other biological markers into regulatory networks, are likely to be necessary to facilitate the integration of genomics into lifestyle medicine in T2D.
2 型糖尿病(T2D)广泛存在,影响着全球数亿人的健康。该疾病是由生活方式因素在遗传 DNA 风险变异体背景下相互作用的复杂过程引起的。检测和理解生物标志物,无论是基因型还是其他下游生物学特征,都可能对预防 T2D 具有巨大的应用价值。在这里,我们探讨了(i)人类对不同的局部环境的遗传适应如何与 T2D 中的生活方式因素相互作用的证据,(ii)T2D 中基因与生活方式相互作用研究领域面临的关键挑战,以及(iii)未来研究中可能采取的解决方案。总的来说,存在许多此类相互作用的初步例子,但没有一个足以对临床决策产生重大影响。未来的研究,将遗传学和其他生物学标志物整合到调控网络中,可能对于将基因组学纳入 T2D 的生活方式医学中是必要的。